<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>E药经理人 | wechat-feeds</title><link>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</link><description>我们致力于成为医药行业意见领袖平台，我们记录和观察医药重大商业事件，展现这个行业的复杂和冲突，提供最前线的思想火花。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sat, 30 Jan 2021 21:03:18 +0800</pubDate><image><url>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</url><title>E药经理人 | wechat-feeds</title><link>http://MjM5NzY2MDQwMg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>一款被CDE驳回的肺癌一类新药，有人“重金”买回来，为什么？</title><link>https://mp.weixin.qq.com/s/yegzhVAjn7tzt5FCeRt_gQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeLibxkPNFukciaX4Xg4UGsKEu411ibG2mvA16CPLkOjCDia4YNK1KrBK6uicgrxA6tEQW7P6cgfCtWgNIg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 30 Jan 2021 18:31:25 +0800</pubDate></item><item><title>第四批集采在即，那些超低价中标的药如今怎样了？</title><link>https://mp.weixin.qq.com/s/-vFwG5Ugo0s9_jWcdGAA7Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeLibxkPNFukciaX4Xg4UGsKEubicgIKcv6pyFfss6jwhw7Kv0ia6vianEcKSjzQVjxXIQd7tIkRibzBkcwQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Sat, 30 Jan 2021 18:31:25 +0800</pubDate></item><item><title>辉瑞、礼来抢先，艾伯维紧随其后，恒瑞国内最快，JAK抑制剂新战场在这里？</title><link>https://mp.weixin.qq.com/s/wewOIOuorZQuOt0n-OM7LQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKiavwYh31rn6eggfOeQtebkHibkDKlxkIibuPJyrnsAIsHRxBwYMBR0n4PyGz6p2ZZw2icN3b5InIl8A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 29 Jan 2021 18:11:26 +0800</pubDate></item><item><title>2020年这家外资药企在中国取得最多新药获批，在疫情笼罩下走出了浓墨重彩的一年</title><link>https://mp.weixin.qq.com/s/RRxdFr1Ao99QGdmFhRXw0g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKUXemZialnrYzwmxV4CQiagSEFBdhq2J2weDqK36MWELpjgMuyYTUtlQcSbTvRq2UDSPvjib3rzlnWA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 29 Jan 2021 18:11:26 +0800</pubDate></item><item><title>齐鲁首个奥氮平口溶膜获批上市，40亿元中国市场正重新洗牌</title><link>https://mp.weixin.qq.com/s/ri7Oi3QEdxhPyJafDnhskQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKUXemZialnrYzwmxV4CQiagSEDMqAwiaZHpIxibwBmJHov2hbu7atS5p8JjKByyXAhnlRvQPQrn5vLwg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 29 Jan 2021 18:11:26 +0800</pubDate></item><item><title>盈利预增620%，新疫苗上市首年销售16亿元！这家公司绝地反击？</title><link>https://mp.weixin.qq.com/s/Z03G7OiXbmG-rFrONtaGYQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKUXemZialnrYzwmxV4CQiagSrY3kQiabJqlR64A7W8TI1J9bzJ3ZYFP4R6Q6kIcVR8c2FHBFWgSqibqw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Fri, 29 Jan 2021 18:11:26 +0800</pubDate></item><item><title>信息量太大！四批集采前，政策出大招：所有医保药品都可能集采？集采外还设专项采购！探索孤儿药、短缺药适宜采购方式</title><link>https://mp.weixin.qq.com/s/tZwtH3-c-f9aTmiKuJIHqQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKiavwYh31rn6eggfOeQtebkd3f9kKQNib2GCMSJFwvVwN6icOIHH0wp0lFUCmBDdAniaYwakHzaBnjmg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Thu, 28 Jan 2021 20:24:28 +0800</pubDate></item><item><title>吉利德中国迎来新总经理？金方千本人回应。</title><link>https://mp.weixin.qq.com/s/j9ZN7n0VwhDafRjPyz_KCA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKiavwYh31rn6eggfOeQtebkibcU3svZ3cd5NqjIedtwI46q9X8pucKibno7tmLLaHaPciaT42INpywPA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Thu, 28 Jan 2021 20:24:28 +0800</pubDate></item><item><title>加码产品结构转型升级，翰森制药生物药研发中心启用</title><link>https://mp.weixin.qq.com/s/VyTuE55474Jlr4Lc-oqnnQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKiavwYh31rn6eggfOeQtebkmZKhk6crEX2U67UoNGODMSGzwf2FBP2ib4J03gg5icFTsze7T5KcAWmg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Thu, 28 Jan 2021 20:24:28 +0800</pubDate></item><item><title>昆药集团携手汉光药业！“双轮驱动”战略落地！</title><link>https://mp.weixin.qq.com/s/y1PyjzlaI4URvx5JCUW9iA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKiavwYh31rn6eggfOeQtebk5gYrkar77p53nBTuKdeRdywaaiaBFPuePZ3KbPhQ2kGtnM24kUSOKhQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Thu, 28 Jan 2021 20:24:28 +0800</pubDate></item><item><title>罗氏占3席涉PD-L1，GSK与赛诺菲不合，AZ全面放弃这一领域？2020临床失败案例TOP10盘点！</title><link>https://mp.weixin.qq.com/s/QCA3IONMEmfmTWs4Q-xN-w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKlE7tpMkgwYLxusH0qcOsL7iaRayJw7qtzK2cX9XYVsk8EzHLCkQBFussIdibZMkprXuTpBAaaFeCw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>一个新药从I期走向上市，临床研究的成功率不到10%。]]></content:encoded><pubDate>Wed, 27 Jan 2021 20:02:13 +0800</pubDate></item><item><title>AZ奥希替尼霸占榜首，辉瑞阿托伐他汀钙“余威”仍在，2020年河南网上交易情况发布！</title><link>https://mp.weixin.qq.com/s/NaRWlf7I_QPrYXGM0A3fXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKlE7tpMkgwYLxusH0qcOsLvXKWY2PaXYZRsx4HTgPaxbBficrlZmtDtIYTh8geCUHt0rECI2iaib0pQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Wed, 27 Jan 2021 20:02:13 +0800</pubDate></item><item><title>小独角兽大天空，港交所迎来第一个NGS基因概念开启招股</title><link>https://mp.weixin.qq.com/s/kyXKAv5OvPLCnVMKdXvEmQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKlE7tpMkgwYLxusH0qcOsLicmKIr6ZgbVJibricfAkz0EGnMCSXqujugZ1hPov6EvSyOyic4Os9W9mCA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>辅助生殖领域的小独角兽，苏州贝康医疗股份有限公司于今日开始招股。]]></content:encoded><pubDate>Wed, 27 Jan 2021 20:02:13 +0800</pubDate></item><item><title>千余种未过评药品遭撤网，恒瑞、扬子江、正大天晴等在列，仿制药淘汰赛加速！</title><link>https://mp.weixin.qq.com/s/URl0F7nI-k-TB7ya5FJZ3Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeKlE7tpMkgwYLxusH0qcOsLFRnPVf6Riab6H5rC1ccT7V5cDDKsVDrib10qMl2Gn1gg1Xgmz4ociaRcA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>千余种未过评药品遭撤网，恒瑞、扬子江、正大天晴等在列，仿制药淘汰赛加速！]]></content:encoded><pubDate>Wed, 27 Jan 2021 20:02:13 +0800</pubDate></item><item><title>一年市值跌掉K药近2年销售额，重押新冠药物研发的默沙东，2021能否扳回一局？</title><link>https://mp.weixin.qq.com/s/wxRA_3HbbgDFZDqt5Wa_nA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJH8M9l53eb77UdDWkUSZgic1HafWDiakkszWhDERHqpes6icegIazHz6wBXnIVdGBcu0GEK3ZYQVbOA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年，疫苗巨头默沙东开年不利，先给“疯狂”的新冠疫苗研发泼了一盆凉水。]]></content:encoded><pubDate>Tue, 26 Jan 2021 19:46:21 +0800</pubDate></item><item><title>罗氏诊断连续11年荣膺“中国杰出雇主”认证</title><link>https://mp.weixin.qq.com/s/t-gdDwX2NkcLTColtoF0tA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeK6dp34edxKUicdZe4smyTGGoaGMQjDUum4rAGHA6LRpWPOMlOru0ZfON9GWByLH7cG3zGM8wiabDxw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021年度中国杰出雇主（Top Employer）榜单隆重揭晓。]]></content:encoded><pubDate>Tue, 26 Jan 2021 19:46:21 +0800</pubDate></item><item><title>医药行业的“私域”：没有流量，只有关系</title><link>https://mp.weixin.qq.com/s/4A2H4Ak940pM0-m9mmbPBQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeJH8M9l53eb77UdDWkUSZgic13hfl7ExgK8fUjNCMzxlBXhetHrgxibtOPvjO23wME39ZwGxu9lEE6w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>随着费用的降低，私域流量逐渐在生命健康领域走红。]]></content:encoded><pubDate>Tue, 26 Jan 2021 19:46:21 +0800</pubDate></item><item><title>转型or消亡？面对biotech后浪“生猛”，人福、罗欣等一众传统药企如何“求生”逆袭？</title><link>https://mp.weixin.qq.com/s/JFBIQ_Dm4oiqxVvzF_BSNQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeK6dp34edxKUicdZe4smyTGGW0PwLBSJgsUwUicD2icibMpmSaZEJjXWbkdicVKkk6DCHjkvqZI4UyUibJg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:50:45 +0800</pubDate></item><item><title>全球累计确诊逼近1亿，疫苗疯狂，抗体挣扎，能救疫情于水火之中吗？</title><link>https://mp.weixin.qq.com/s/JN9589qOfdZ108PFuyIo_g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeK6dp34edxKUicdZe4smyTGGFZmg0mJHe3ENaicsluiayqHQWTwuFhjUpxHgFaZ9YJoqgTibIGMiaBYBDA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:50:45 +0800</pubDate></item><item><title>绿叶制药：以差异化创新固牢竞争壁垒</title><link>https://mp.weixin.qq.com/s/cvpyNYG1tVnbkVaAL7CWVg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/bASSOTgOKeK6dp34edxKUicdZe4smyTGGUWuNIBZicicvMHIREIjcpegT2hia9dd5IEEkSxXibRo0YuI72ywwQp503w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>E药经理人]]></content:encoded><pubDate>Mon, 25 Jan 2021 21:50:45 +0800</pubDate></item></channel></rss>